April 2019 - Cancer Currents Blog
-
Telephone-Based Rehab Program Helps People with Advanced Cancer Maintain IndependenceA physical rehabilitation program delivered by telephone improved function and reduced pain for people with advanced cancer, a clinical trial shows. The program also reduced the time patients spent in hospitals and long-term care facilities.
-
Immunotherapy Drug with Two Targets Shows Promise against HPV-Related CancersThe investigational immunotherapy drug bintrafusp alfa (also called M7824), a bifunctional fusion protein, shrank the tumors of some patients with advanced HPV-related cancers, according to results from a phase 1 clinical trial.
-
Study Advances Fertility Preservation Approach for Male Cancer SurvivorsIn a study in young monkeys, researchers showed that a technique using stored testicular tissue led to successful conception. Researchers are hopeful the approach could eventually be a fertility preservation option for young boys being treated for cancer.
-
Could a Vaccine Prevent Colorectal Cancer in People with Lynch Syndrome?Findings from an NCI-funded study suggest a new vaccine approach may have the potential to prevent colorectal cancer in people with Lynch syndrome, an inherited condition that increases an individual's risk for developing certain types of cancer.
-
Ensuring a Smooth Leadership Transition at NCIDoug Lowy, M.D., a long-time researcher and deputy director at NCI, addresses the cancer community as the institute's acting director, a position he previously held for more than 2 years.
-
Fewer Women with Ovarian, Breast Cancer Undergo Genetic Testing than ExpectedMany women diagnosed with ovarian and breast cancer are not undergoing tests for inherited genetic mutations that can provide important information to help guide decisions about treatment and longer-term cancer screening, a new study has found.
-
Researchers Discover Potential Way to Hit Elusive Target in Pancreatic CancerThree research groups have found a potential way to kill cancer cells in pancreatic tumors by simultaneously blocking the activity of proteins that interact with KRAS proteins and disrupting an energy-creating process called autophagy.